Search results (32)
« Back to NewsVacancy: Postdoctoral Researcher – Signalling cross talks between cancer cells and infiltrating tumour monocytes and T cells
7 April 2025
Research Grade 7: £38,674 - £46,913 with a discretionary range to £52,539 p.a. This is inclusive of a pensionable Oxford University Weighting of £1,500 per year
Production of biocompatible multifunctional modular iontronics enabled by microscale droplet assembly
29 November 2024
The Lu lab collaborates with the École Polytechnique Fédérale de Lausanne and Oxford departments to report the use of surfactant-supported assembly of freestanding microscale hydrogel droplets to construct iontronic modules and biointerfaces.
Ludwig Oxford at 2024 AACR
17 April 2024
Ludwig Oxford staff and students alike share their research in San Diego at the 2024 AACR Annual Meeting
International Women's Day within Ludwig Oxford
8 March 2024
The 8th March annually celebrates Women's achievements and we are delighted to celebrate the women researchers, students and staff within Ludwig Oxford
Factor-inhibiting HIF deficiency is found to create a tumour-promoting immune microenvironment
1 March 2024
A collaborative study by the Lu and Ratcliffe research groups has found that the tumour-promoting immune microenvironment can be created by a deficiency in factor-inhibiting HIF.
New DPhil studentships in Cancer Science available for 2024 intake
30 October 2023
Ludwig Oxford supervised DPhil studentships in Cancer Science are now being advertised for the 2024 intake
A role for ASPP2 in Hepatitis C infection
28 September 2023
Ludwig Oxford researchers in the Lu lab uncover new insights into the role of ASPP2 in Hepatitis C virus replication and transmission.
Ludwig Oxford clinical trial shows Immunochemotherapy outcomes predicted by tumour monocyte content
11 July 2023
An analysis of samples obtained from a uniquely designed window-of-opportunity clinical trial (LUD2015-005) has shown that high tumour monocyte content (TMC) is an unexpected predictor of greater overall survival in inoperable oesophageal adenocarcinoma (OAC) patients.
p53 inhibitor iASPP acts as a surprise pancreatic cancer suppressor
9 June 2023
Ludwig Oxford’s Xin Lu shows an unexpected suppression of KRAS and inflammation driven pancreatic cancer by the p53 suppressor iASPP.
iASPP as a regulator of immunological tolerance
6 February 2023
Researchers from the Lu lab identify iASPP to be a key component in the anti-tumour immune response
Professor Xin Lu featured in Ludwig's Women in Science report
24 November 2022
Ludwig Oxford’s Professor Xin Lu recounts her experiences in Ludwig Cancer Research’s special Women in Science report.
Ludwig Oxford student awarded NDM graduate student prize
18 November 2022
Dr Tom Carroll from the Lu lab receives a Highly Commended award under the NDM overall graduate student prize
Mechanistic insights into the ZBP1 inflammatory response
21 October 2022
A collaborative study, led by former Ludwig Oxford group leader Professor Mads Gyrd-Hansen, sheds light on the ZBP1-induced signalling pathway, a pathway which contributes to the viral immune response, including to SARS-CoV-2
Unexpected role of iASPP as a tumour suppressor
18 October 2022
The Lu lab reveals that the previously characterised oncogene, iASPP, acts as a tumour suppressor in mutant RAS- and inflammation-driven skin cancers.
Mathematical methods for analysing single-cell transcriptomic data
17 August 2022
An interdisciplinary collaboration has resulted in the development of three multiscale data methods for the analysis of single-cell transcriptomic data that have advantages over current methods.
Ludwig Oxford student features in the Oxford Botantic Garden 400th Anniversary celebrations
2 August 2022
On Saturday 30th July, PhD student Hannah Fuchs gave a soapbox talk on plant-derived cancer treatments.
Ludwig Oxford Director Professor Xin Lu elected as Academia Europaea member
19 July 2022
Professor Xin Lu joins >4600 other eminent academic members from across Europe.
Ludwig Oxford retreat 2022 – a recap
15 July 2022
- Barnes
- Boccellato
- Byrne
- Constantinescu
- De Val
- Goding
- Kriaucionis
- Lu
- Mehdipour
- Moura Alves
- Ratcliffe
- Schuster-Böckler
- Shi
- Song
- Van den Eynde
On 13-14th June 2022, the Oxford Branch of the Ludwig Institute for Cancer Research held their annual retreat to discuss key scientific advances within the Branch and beyond.
Unexpected hydroxylation
20 May 2022
Biochemical and structural data reveals a site on ankyrin repeat domain proteins for double hydroxylation by Factor Inhibiting Hypoxia Inducible Factor (FIH).
Ludwig Oxford at AACR 2022
8 April 2022
Several Ludwig Oxford researchers present at the American Association for Cancer Research (AACR) Annual Meeting.